ATH (Inflazyme)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameATH (Inflazyme)
Drug Alias NameATH (GLYCODesign)antithrombib/heparin complex (Inflazyme)antithromib/heparin complex (GLYCODesign)ATHt (Inflazyme)ATH
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeparin agonistsAntithrombin-III replacements
TargetsHeparin
Therapy Area/IndicationsVenous ThrombosisThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlycodesign Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A